Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 15, 2017

Primary Completion Date

January 11, 2023

Study Completion Date

June 30, 2024

Conditions
Metastatic Breast Cancer
Interventions
DIAGNOSTIC_TEST

FES PET/CT

"There will be no premedication or other treatment before and after PET FES. PET / CT will be performed at the center level on a hybrid PET camera.~* The first TEP FES acquisition begins at the time of injection and continues for 30 minutes,~* The second acquisition of 20 minutes takes place 60 minutes after the injection is a total of 50 minutes of imaging and 1:30 in the service."

Trial Locations (4)

21079

Centre Georges François Leclerc, Dijon

29200

CHU de Brest, Brest

44805

ICO René Gauducheau, Saint-Herblain

49055

Institut de Cancerologie de l'Ouest, Angers

All Listed Sponsors
lead

Institut Cancerologie de l'Ouest

OTHER

NCT03442504 - Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter